Prescription medicines: U.S. spending growth 2000-2024

Statista2026-04-11 收录

处方药费用

医疗保健经济评估

数据链接：

https://www.statista.com/statistics/215472/spending-growth-for-prescription-medicines-in-the-us/数据链接链接失效反馈

官方服务：

资源简介：

Spending growth for prescription medicines in the U.S. from 2000 to 2024

Results of the baseline cost-utility analysis for RRD surgery in an elderly population (bootstrap, n = 1000).

老年RRD手术成本-效用分析

医疗保健经济评估

*Comparisons were made between age groups of patients in their 70s and 80s using a Mann Whitney U test. A value of P<0.05 was regarded as statistically significant. RRD, rhegmatogenous retinal detachm

NIAID Data Ecosystem60

布基纳法索 BF：医疗保健支出：共计：占国内生产总值百分比

医疗保健经济评估

公共卫生支出

（停止更新）医疗保健支出：占国内生产总值百分比在12-01-2014达4.960%，相较于12-01-2013的5.912%有所下降。（停止更新）医疗保健支出：占国内生产总值百分比数据按年更新，12-01-1995至12-01-2014期间平均值为6.453%，共20份观测结果。该数据的历史最高值出现于12-01-2009，达7.405%，而历史最低值则出现于12-01-2001，为4.852%。

CEIC Data50

U.S. household expenditure on prescription drugs 2007-2023

医疗保健支出

处方药费用

Average annual expenditure on prescription drugs per consumer unit in the United States from 2007 to 2023 (in U.S. dollars)

Statista40

Economic Evaluation of a General Hospital Unit for Older People with Delirium and Dementia (TEAM Randomised Controlled Trial)

医疗保健经济评估

认知障碍护理

BackgroundOne in three hospital acute medical admissions is of an older person with cognitive impairment. Their outcomes are poor and the quality of their care in hospital has been criticised. A speci

Figshare2016-01-15 更新60

Summary statistics for the main, sensitivity, and subgroup cost-utility bootstrap analyses.

医疗保健经济评估

成本效益分析

Summary statistics for the main, sensitivity, and subgroup cost-utility bootstrap analyses.

NIAID Data Ecosystem40